RAPT Therapeutics, Inc. (RAPT) has a market capitalization of $959.26M and trades at $58.01. The 52-week range is 5.6652-58.02.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -18.2, Earnings Per Share (EPS) of $-3.19.
The stock has a beta of 0.44, operates in the Healthcare sector.
